Vifor Pharma Group announced the appointment of acting Chief Financial Officer Alexandros Sigalas and Group General Counsel Dr. Oliver P. Kronenberg as members of the Vifor Pharma Executive Committee, effective 1 February 2022. Alexandros Sigalas, Executive at Vifor Pharma and currently Global Head of Finance, will become acting Chief Financial Officer and succeeds Colin Bond who retired from the company at the end of 2021 at his own request. The Swiss citizen holds a Licentiate Degree (M.Sc.) in Accounting and Business Management from University of St.

Gallen and is a Certified Public Accountant in Switzerland. Dr. Oliver P. Kronenberg, a Swiss citizen, joined Vifor Pharma in 2008. Following his tenure as Group General Counsel of Galenica Group from 2013 until the successful IPO of Galenica Santé in 2017, he resumed his previous role as Group General Counsel of Vifor Pharma.